Skip to content
Clinical Trials – home
Research site

Szpital Wolski Im. Dr Anny Gostynskiej Sp. z o.o.

Poland Ul. Ulica Marcina Kasprzaka 17, 01-211 Warsaw, Poland

  • 1 trial recruiting
  • Relapsing multiple sclerosis · Secondary progressive multiple sclerosis · Progressive relapsing multiple sclerosis
  • Adult patients

About Specializations

Szpital Wolski Im. Dr Anny Gostynskiej Sp. z o.o. in Warsaw, Poland specialises in clinical trials of conditions such as Relapsing multiple sclerosis, Secondary progressive multiple sclerosis, Progressive relapsing multiple sclerosis, Ischaemic stroke, and other specialisations. This site conducts important research.

Main research areas of the site

Nervous System Diseases

At Szpital Wolski Im. Dr Anny Gostynskiej Sp. z o.o. in Warsaw, clinical research in nervous system diseases focuses on multiple sclerosis, especially forms linked to progressive disability. These studies aim to evaluate whether new treatments can slow disease worsening and improve long-term outcomes for people living with complex neurological conditions.

  • Research in Primary Progressive Multiple Sclerosis and nonrelapsing secondary progressive multiple sclerosis
  • Testing new therapies designed to delay disability progression
  • Assessing treatment effectiveness and safety in advanced multiple sclerosis

This work reflects a strong neurology-focused program, with investigators exploring whether emerging approaches can better address progressive disease than current care alone.

Cardiovascular Diseases

The site also conducts trials in cardiovascular diseases, with attention to acute myocardial infarction including both ST-elevation and non-ST-elevation heart attacks. The research is centered on reducing the risk of major heart-related complications and improving recovery after a recent cardiac event.

  • Studies in acute myocardial infarction and post-heart attack care
  • Evaluating a new therapy for lowering major adverse cardiovascular events
  • Exploring anti-inflammatory treatment strategies to support better cardiovascular outcomes

These trials combine cardiology and inflammation-focused research to test whether earlier intervention can help protect patients after myocardial infarction.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Ul. Ulica Marcina Kasprzaka 1701-211 WarsawPoland
Recruiting now
1 trial
Conditions studied
9

More sites in WarsawPoland

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

5 clinical trials

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Teriflunomide
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Ischaemic stroke+2

Not recruiting
Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Asundexian
  • Sponsor:Bayer AG
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Ziltivekimab
  • Sponsor:Novo Nordisk A/S

Multiple sclerosis

Not recruiting
Investigational
Countries:PolandPoland
  • Participants:18–64 years
  • Substances:Frexalimab
  • Sponsor:Sanofi-Aventis Recherche & Developpement
Investigational
Countries:PolandPoland
  • Participants:18–64 years
  • Substances:Tolebrutinib
  • Sponsor:Genzyme Corp.
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.